Adjuvant systemic treatment for high-risk resected non-cutaneous melanomas: what is the evidence?

Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer

Expert Review of Gastroenterology & Hepatology ◽

10.1080/17474124.2021.1890031 ◽

2021 ◽

pp. 1-8 ◽

Cited By ~ 4

Author(s):

Alessandro Rizzo ◽

Giovanni Brandi

Keyword(s):

Biliary Tract ◽

Biliary Tract Cancer ◽

Systemic Treatment ◽

Tract Cancer ◽

Adjuvant systemic treatment for individual patients with triple negative breast cancer

The Breast ◽

10.1016/s0960-9776(11)70311-3 ◽

2011 ◽

Vol 20 ◽

pp. S135-S141 ◽

Cited By ~ 11

Author(s):

Catherine Oakman ◽

Erica Moretti ◽

Francesca Galardi ◽

Chiara Biagioni ◽

Libero Santarpia ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Systemic Treatment ◽

Outcome without any adjuvant systemic treatment in stage I ER+/HER2- breast cancer patients included in the MINDACT trial

Annals of Oncology ◽

10.1016/j.annonc.2021.11.014 ◽

2021 ◽

Author(s):

J.M.N. Lopes Cardozo ◽

D. Byng ◽

C.A. Drukker ◽

M.K. Schmidt ◽

M.A. Binuya ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Systemic Treatment ◽

Stage I ◽

Breast Cancer Patients ◽

Her2 Breast Cancer

The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment

Annals of Oncology ◽

10.1093/annonc/mdp273 ◽

2010 ◽

Vol 21 (1) ◽

pp. 40-47 ◽

Cited By ~ 39

Author(s):

J.M. Bueno-de-Mesquita ◽

D.S.A. Nuyten ◽

J. Wesseling ◽

H. van Tinteren ◽

S.C. Linn ◽

...

Keyword(s):

Breast Cancer ◽

Systemic Treatment ◽

Observer Variation ◽

Node Negative ◽

Node Negative Breast Cancer ◽

Clinical Risk Assessment ◽

Selection For ◽

The Impact ◽

Pathological Assessment

Long-term subjective cognitive functioning following adjuvant systemic treatment: 7–9 years follow-up of a nationwide cohort of women treated for primary breast cancer

British Journal of Cancer ◽

10.1038/bjc.2015.243 ◽

2015 ◽

Vol 113 (5) ◽

pp. 794-801 ◽

Cited By ~ 15

Author(s):

A Amidi ◽

S Christensen ◽

M Mehlsen ◽

A B Jensen ◽

A D Pedersen ◽

...

Keyword(s):

Breast Cancer ◽

Cognitive Functioning ◽

Primary Breast Cancer ◽

Systemic Treatment ◽

Inter-observer variation in pathological review and its impact on clinicopathological risk assessment and patient selection for adjuvant systemic treatment in node-negative breast cancer patients

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(08)70790-0 ◽

2008 ◽

Vol 6 (7) ◽

pp. 191

Author(s):

J.M. Bueno-de-Mesquita ◽

D.S.A. Nuyten ◽

J. Wesseling ◽

H. Van Tinteren ◽

S.C. Linn ◽

...

Keyword(s):

Breast Cancer ◽

Risk Assessment ◽

Systemic Treatment ◽

Observer Variation ◽

Breast Cancer Patients ◽

Node Negative ◽

Node Negative Breast Cancer ◽

Pathological Review ◽

Selection For

Abstract OT3-3-02: ASTER 70s UNICANCER phase III trial: Can a genomic prognosticator help tailoring adjuvant systemic treatment for luminal breast carcinoma in elderly women?

10.1158/1538-7445.sabcs14-ot3-3-02 ◽

2015 ◽

Author(s):

Coraline Dubot ◽

Emmanuelle Bourbouloux ◽

Olivier Mir ◽

Sylvie Kirscher ◽

Olivier Rigal ◽

...

Keyword(s):

Breast Carcinoma ◽

Elderly Women ◽

Systemic Treatment ◽

Phase Iii ◽

Phase Iii Trial ◽

Abstract P2-14-19: Patients’ experience with 70-gene signature testing on adjuvant systemic treatment decisions: Results of a prospective cohort study

10.1158/1538-7445.sabcs19-p2-14-19 ◽

2020 ◽

Author(s):

Julia E.C. van Steenhoven ◽

Bianca den Dekker ◽

Anne Kuijer ◽

Sjoerd G. Elias ◽

Paul J. van Diest ◽

...

Keyword(s):

Cohort Study ◽

Prospective Cohort Study ◽

Prospective Cohort ◽

Systemic Treatment ◽

Gene Signature ◽

Treatment Decisions ◽

Patients Experience

Is There a Role for Neo-Adjuvant Systemic Treatment in Sts?

Annals of Oncology ◽

10.1093/annonc/mdu309.2 ◽

2014 ◽

Vol 25 ◽

pp. iv31

Author(s):

J. Martín Broto

Keyword(s):

Systemic Treatment ◽

159O Prognostic value of tumour infiltrating lymphocytes in young triple negative breast cancer patients who did not receive adjuvant systemic treatment; by the PARADIGM study group

Annals of Oncology ◽

10.1016/j.annonc.2020.08.281 ◽

2020 ◽

Vol 31 ◽

pp. S303

Author(s):

V.M.T. De Jong ◽

Y. Wang ◽

M. Opdam ◽

N. ter Hoeve ◽

K. Jóźwiak ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Triple Negative Breast Cancer ◽

Prognostic Value ◽

Triple Negative ◽

Systemic Treatment ◽

Study Group ◽

Breast Cancer Patients ◽

Infiltrating Lymphocytes